IMGN:
Analysis & Opinions
-
February 14, 2013
ImmunoGen, Inc. (IMGN) recently announced that it has finished enrolling patients for the initial stage of the ...
-
January 28, 2013
ImmunoGen Inc. (IMGN) reported second quarter fiscal 2013 adjusted loss of 29 cents per share, wider than both the ...
-
October 26, 2012
The market is having a bad day so far: the Nasdaq has slipped 0.1%; the S&P 500 has declined 0.2%; and the Dow is ...
-
October 02, 2012
Roche Holdings Ltd. (RHHBY) recently announced additional results from its phase III EMILIA study, which was ...
-
September 27, 2012
After this morning's trading, the Nasdaq has increased 0.4%, the S&P 500 has moved up 0.3% and the Dow has remained ...
-
September 27, 2012
After the morning's trading, the Nasdaq has increased 0.4%, the S&P 500 has risen 0.3% and the Dow has moved little. ...
-
August 27, 2012
Roche Holdings Ltd. (RHHBY) recently announced results from its phase III study (EMILIA study) of trastuzumab ...
-
August 27, 2012
The market is on the rise this morning. The Nasdaq is up 0.5%; the S&P 500 has risen 0.3%; and the Dow has climbed ...
-
July 12, 2012
The market is currently down, with the Nasdaq decreasing 1.3%, the S&P 500 falling 0.8% and the Dow declining 0.5%. ...
-
June 05, 2012
As the world continues to modernize and grow, global cancer incidences are expected to increase exponentially and ...
-
May 03, 2011
Check out April's Best Performing Healthcare Stocks!
-
August 27, 2010
Roche suffers another setback to its key cancer franchise, while ImmunoGen faces a major delay in royalty payments.
